Dr. Caralynn Nowinski Collens is the CEO of Dimension Inx, an emerging leader in biofabrication, leveraging a patented biomaterials platform to create regenerative medical products that fundamentally change how we treat human disease and debilitation. She is passionate about building teams and organizations that harness technology to drive transformational change and improve the quality of people’s lives.
Previously as the co-founder of UI LABS, a first-of-its-kind technology organization focused on the digital future of industries, Caralynn built the organization from concept in late 2011 through launch in 2014, raising $200M+ in investment and ultimately spinning out two business units as independent entities in 2019. After starting her first company while a joint medical/business student at the University of Illinois at Chicago, Caralynn spent her early career in venture capital and corporate finance, primarily focused on technology-based university spin-outs.
Caralynn is Chairman Emeritus of the Board of Directors of MxD (national digital manufacturing institute) and serves on the Executive Council of Granite Creek Capital Partners. She is proud to have been a member of the Chicago Chapter of the Young Presidents’ Organization (YPO) and recognized as one of Crain’s Chicago Business’ “Forty Under Forty”.